Ali J. Satvat - Net Worth and Insider Trading

Ali J. Satvat Net Worth

The estimated net worth of Ali J. Satvat is at least $3.0 Billion dollars as of 2024-11-08. Ali J. Satvat is the Director, 10% Owner of Eidos Therapeutics Inc and owns about 24,575,501 shares of Eidos Therapeutics Inc (EIDX) stock worth over $3.0 Billion. Details can be seen in Ali J. Satvat's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ali J. Satvat has not made any transactions after 2019-07-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Ali J. Satvat

To

Ali J. Satvat Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ali J. Satvat owns 4 companies in total, including BridgeBio Pharma Inc (BBIO) , Eidos Therapeutics Inc (EIDX) , and Coherus BioSciences Inc (CHRS) among others .

Click here to see the complete history of Ali J. Satvat’s form 4 insider trades.

Insider Ownership Summary of Ali J. Satvat

Ticker Comapny Transaction Date Type of Owner
BBIO BridgeBio Pharma Inc 2019-06-27 director
EIDX Eidos Therapeutics Inc 2020-05-27 director & 10 percent owner
CHRS Coherus BioSciences Inc 2016-05-24 director
LIMIT LIMIT 2021-04-22 director

Ali J. Satvat Latest Holdings Summary

Ali J. Satvat currently owns a total of 1 stock. Ali J. Satvat owns 24,575,501 shares of Eidos Therapeutics Inc (EIDX) as of July 3, 2019, with a value of $3.0 Billion.

Latest Holdings of Ali J. Satvat

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EIDX Eidos Therapeutics Inc 2019-07-03 24,575,501 122.21 3,003,371,977

Holding Weightings of Ali J. Satvat


Ali J. Satvat Form 4 Trading Tracker

According to the SEC Form 4 filings, Ali J. Satvat has made a total of 0 transactions in Eidos Therapeutics Inc (EIDX) over the past 5 years. The most-recent trade in Eidos Therapeutics Inc is the acquisition of 882,353 shares on July 3, 2019, which cost Ali J. Satvat around $26 Million.

Insider Trading History of Ali J. Satvat

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ali J. Satvat Trading Performance

GuruFocus tracks the stock performance after each of Ali J. Satvat's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ali J. Satvat is 1.71%. GuruFocus also compares Ali J. Satvat's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ali J. Satvat within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ali J. Satvat's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ali J. Satvat

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.03 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -8.3 LIMIT LIMIT LIMIT LIMIT LIMIT

Ali J. Satvat Ownership Network

Ownership Network List of Ali J. Satvat

No Data

Ownership Network Relation of Ali J. Satvat

Insider Network Chart

Ali J. Satvat Owned Company Details

What does BridgeBio Pharma Inc do?

Who are the key executives at BridgeBio Pharma Inc?

Ali J. Satvat is the director of BridgeBio Pharma Inc. Other key executives at BridgeBio Pharma Inc include 10 percent owner Kkr Genetic Disorder L.p. , director & See Remarks Neil Kumar , and See Remarks Brian C Stephenson .

BridgeBio Pharma Inc (BBIO) Insider Trades Summary

Over the past 18 months, Ali J. Satvat made no insider transaction in BridgeBio Pharma Inc (BBIO). Other recent insider transactions involving BridgeBio Pharma Inc (BBIO) include a net sale of 12,000 shares made by Randal W Scott , a net sale of 182,045 shares made by Neil Kumar , and a net sale of 73,947 shares made by Brian C Stephenson .

In summary, during the past 3 months, insiders sold 5,831,544 shares of BridgeBio Pharma Inc (BBIO) in total and bought 0 shares, with a net sale of 5,831,544 shares. During the past 18 months, 7,676,737 shares of BridgeBio Pharma Inc (BBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,676,737 shares.

BridgeBio Pharma Inc (BBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BridgeBio Pharma Inc Insider Transactions

No Available Data

Ali J. Satvat Mailing Address

Above is the net worth, insider trading, and ownership report for Ali J. Satvat. You might contact Ali J. Satvat via mailing address: C/o Kohlberg Kravis Roberts & Co., 2800 Sand Hill Road, Suite 200, Menlo Park Ca 94025.